Search companies on Owler
Advanced Search
Latest news
Newsfeed
My followed companies
Followed Companies

Monte Rosa is a biotechnology company that develops and commercializes TPD therapies for the treatment of cancer. Read more

Monte Rosa is a biotechnology company that develops and commercializes TPD therapies for the treatment of cancer. Read more

Markus Warmuth's photo - CEO of Monte Rosa

CEO

Markus Warmuth

CEO Approval Rating

90/100

Founded:

2020

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector
Pharmaceuticals
Headquarters

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

The top 10 competitors in Monte Rosa's competitive set are Kymera Therapeutics, Inc., C4T, Nurix, Cedilla, Jounce, NexImmune, Juno Therapeutics, Aura Biosciences, Arvinas. Together they have raised over 4.4B between their estimated 1.7K employees. Monte Rosa has 30 employees and is ranked 14th among it's top 10 competitors. The top 10 competitors average 1,497.

Kymera Therapeutics, Inc. is one of Monte Rosa's top competitors. Kymera Therapeutics, Inc. is a Public company that was founded in Watertown, Massachusetts in 2016. Kymera Therapeutics, Inc. is in the Biotechnology field. Kymera Therapeutics, Inc. has 25 more employees vs. Monte Rosa.

C4T is perceived as one of Monte Rosa's biggest rivals. C4T was founded in 2010 in Watertown, Massachusetts. C4T competes in the Biotechnology industry. C4T generates $21.4M more revenue than Monte Rosa.

Nurix is a top competitor of Monte Rosa. Nurix's headquarters is in San Francisco, California, and was founded in 2009. Nurix competes in the Biotechnology field. Nurix generates ∞% of Monte Rosa's revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is $ < 1M a good estimate for Monte Rosa's revenue?

I don't know

Acquisitions

No recent acquisitions found related to Monte Rosa

Monte Rosa Funding History

$128.5M

Since Monte Rosa was founded in 2020, it has participated in 2 rounds of funding. In total Monte Rosa has raised $128.5M. Monte Rosa's last funding round was on Sep 2020 for a total of $96.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series B
Sep 2020
$96M

Aisling Capital

Series A
May 2020
$32.5M

Total Funding: $128.5M

Since Monte Rosa was founded in 2020, it has participated in 2 rounds of funding. In total Monte Rosa has raised $128.5M. Monte Rosa's last funding round was on Sep 2020 for a total of $96.0M

Investments

No recent investments found related to Monte Rosa

Monte Rosa News

September 28, 2020Global Legal Chronicle

Monte Rosa Therapeutics' $96 Million Series B Financing

Wilson Sonsini Goodrich & Rosati advised Monte Rosa Therapeutics on the deal. Monte Rosa Therapeutics... See more »
September 25, 2020startupticker

Monte Rosa Therapeutics Closes $96 Million Series B Financing

The financing will enable Monte Rosa to accelerate the growth of its pipeline, advance development ca... See more »
September 24, 2020Xconomy

Monte Rosa Raises $96M for "Glue-Based" Protein Degrading Drugs

Many drugs work by binding to a protein and blocking it. Technology for eliminating disease-causing p... See more »
September 24, 2020The Business Journals

Biotech focused on protein degradation raises $96M in 2nd fundraising this year

Monte Rosa Therapeutics has raised more than $128 million this year.... See more »

Monte Rosa Press Releases

Social Media

Headquarters

40 Guest St

Boston, Massachusetts02135

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Monte Rosa is a biotechnology company that develops and commercializes TPD therapies for the treatment of cancer. Monte Rosa was founded in 2020. Monte Rosa's headquarters is located in Boston, Massachusetts, USA 02135. It has raised 128.5M in 2 round...

CEO

Monte Rosa's CEO, Markus Warmuth, currently has an approval rating of 90%. Monte Rosa's primary competitors are Kymera Therapeutics, Inc., C4T & Nurix.

Website

monterosatx.com

Frequently Asked Questions about Monte Rosa

  1. When was Monte Rosa founded?

    Monte Rosa was founded in 2020

  2. Who is Monte Rosa's CEO?

    Monte Rosa's CEO is Markus Warmuth

  3. How much revenue does Monte Rosa generate?

    Monte Rosa generates $ < 1M in revenue

  4. How much funding does Monte Rosa have?

    Monte Rosa has historically raised $128.5M in funding

  1. Where is Monte Rosa's headquarters?

    Monte Rosa's headquarters is in Boston Massachusetts, USA

  2. How many employees does Monte Rosa have?

    Monte Rosa has 30 employees

  3. What sector does Monte Rosa operate in?

    Monte Rosa is in Pharmaceuticals

  4. Who are Monte Rosa's competitors?

    Monte Rosa's top competitors are Kymera Therapeutics, Inc., C4T, Nurix
Stay up-to-date with the latest news on Monte Rosa

© 2021 Owler, Inc.